Similarly, treatment of the CryABR120G mutant mouse model of desmin-related cardiomyopathy with the drug geranylgeranyl-acetone (increasing HSPB8 and HSPB1) significantly reduces heart failure (36). This evidence concerns the gene HSPB1 and heart failure.